The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT
Gozlan, H., El Mestikawy, S., Pichat, L., Glowinski, J., & Hamon, M. (1983) · Nature · doi:10.1038/305140a0 · Cited by 758
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
Buckley, N. J., Bonner, T. I., Buckley, C. M., & Brann, M. R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11261-3 · Cited by 635
De Lean, A., Hancock, A. A., & Lefkowitz, R. J. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14584-7 · Cited by 591
Morrow, A. L., & Creese, I. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10258-7 · Cited by 466
Fleming, W. W., Westfall, D. P., de la Lande, I. S., et al. (1972) · PubMed · Cited by 429
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
Bolden-Watson, C., & Richelson, E. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90194-8 · Cited by 390
Self-citationPeroutka, S. J. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb04532.x · Cited by 344
Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
Richelson, E., & Nelson, A. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21446-x · Cited by 341
Self-citationBolden, C., Cusack, B., & Richelson, E. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11335-9 · Cited by 272
Self-citation
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Structure of the human histamine H1 receptor complex with doxepin
Shimamura, T., Shiroishi, M., Weyand, S., Tsujimoto, H., Winter, G., Katritch, V., Abagyan, R., Cherezov, V., Liu, W., Han, G. W., et al. (2011) · Nature · doi:10.1038/nature10236 · Cited by 804
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Artigas, F., Romero, L., de Montigny, C., & Blier, P. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10037-0 · Cited by 655
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Norepinephrine Controls Astroglial Responsiveness to Local Circuit Activity
Paukert, M., Agarwal, A., Cha, J., Doze, V. A., Kang, J. U., & Bergles, D. E. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.038 · Cited by 556
Furey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417
Garnock-Jones, K. P., & Keating, G. M. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00005 · Cited by 392
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303
Pérez, V., Gilaberte, I., Faries, D., Alvarez, E., & Artigas, F. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08007-5 · Cited by 300
Pharmacology of Antidepressants
Frazer, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704001-00002 · Cited by 269
Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review
Drevets, W. C., Zarate, C. A., & Furey, M. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.031 · Cited by 195
Miller, H. L. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020031005 · Cited by 192
The molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
Synaptic Effects of Antidepressants
RICHELSON, E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606002-00001 · Cited by 120
Self-citationInvolvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
Nguyen, L., Robson, M. J., Healy, J. R., Scandinaro, A. L., & Matsumoto, R. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089985 · Cited by 99
GSK3β: a master player in depressive disorder pathogenesis and treatment responsiveness
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020) · Cells · doi:10.3390/cells9030727 · Cited by 84
Hicks, J. A., Argyropoulos, S. V., Rich, A. S., Nash, J., Bell, C. J., Edwards, C., Nutt, D. J., & Wilson, S. J. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.6.528 · Cited by 84
Third-Generation Antidepressants: Do They Offer Advantages Over the SSRIs?
Olver, J. S., Burrows, G. D., & Norman, T. R. (2001) · CNS Drugs · doi:10.2165/00023210-200115120-00004 · Cited by 63
Abdelmawla, Langley, Szabadi, & Bradshaw (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00031.x · Cited by 58
Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†
Garnock-Jones, K. P., & Keating, G. M. (2010) · CNS Drugs · doi:10.2165/11203670-000000000-00000 · Cited by 32
Wilson, S. J., Bailey, J. E., Alford, C., Weinstein, A., & Nutt, D. J. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600406 · Cited by 30
Husarova, V., Bittsansky, M., Ondrejka, I., & Dobrota, D. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.03.003 · Cited by 19
Antos, Z., Żukow, X., Bursztynowicz, L., & Jakubów, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413658 · Cited by 21
General Principles of Pharmacokinetics
Preskorn, S. H., & Catterson, M. L. (2004) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-18500-7_2 · Cited by 14
Metadata
- Authors
- Cusack, B., Nelson, A., & Richelson, E.
- Venue
- Psychopharmacology
- Published
- 1994-05
- Volume
- 114
- Issue
- 4
- Pages
- 559-565
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1975377762
- Cited by
- 349
- References
- 18
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.